| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXON | Common Stock | Options Exercise | $28,873 | +167 | +0.01% | $172.89 | 2,066,072 | 17 Nov 2021 | Direct | |
| transaction | AXON | Common Stock | Sale | $3,600 | -20 | -0% | $180.00 | 2,066,052 | 17 Nov 2021 | Direct | F1 |
| transaction | AXON | Common Stock | Sale | $14,400 | -80 | -0% | $180.00 | 2,065,972 | 17 Nov 2021 | Direct | F2 |
| transaction | AXON | Common Stock | Options Exercise | $2,090,020 | +11,982 | +0.58% | $174.43 | 2,077,954 | 18 Nov 2021 | Direct | |
| transaction | AXON | Common Stock | Sale | $260,684 | -1,447 | -0.07% | $180.16 | 2,076,507 | 18 Nov 2021 | Direct | F1, F3 |
| transaction | AXON | Common Stock | Sale | $1,043,097 | -5,790 | -0.28% | $180.16 | 2,070,717 | 18 Nov 2021 | Direct | F2, F3 |
| transaction | AXON | Common Stock | Options Exercise | $38,660,613 | +212,491 | +10% | $181.94 | 2,283,208 | 19 Nov 2021 | Direct | |
| transaction | AXON | Common Stock | Sale | $4,310,317 | -23,879 | -1% | $180.51 | 2,259,329 | 19 Nov 2021 | Direct | F1, F4 |
| transaction | AXON | Common Stock | Sale | $382,613 | -2,107 | -0.09% | $181.59 | 2,257,222 | 19 Nov 2021 | Direct | F1, F5 |
| transaction | AXON | Common Stock | Sale | $10,388,838 | -57,210 | -2.5% | $181.59 | 2,200,012 | 19 Nov 2021 | Direct | F2, F5 |
| transaction | AXON | Common Stock | Sale | $7,907,015 | -43,354 | -2% | $182.38 | 2,156,658 | 19 Nov 2021 | Direct | F2, F6 |
| transaction | AXON | Common Stock | Sale | $618,923 | -3,380 | -0.16% | $183.11 | 2,153,278 | 19 Nov 2021 | Direct | F2, F7 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXON | Employee Stock Option | Options Exercise | $0 | -167 | -0.02% | $0.000000 | 682,032 | 17 Nov 2021 | Common Stock | 167 | $28.58 | Direct | |
| transaction | AXON | Employee Stock Option | Award | $0 | +530,488 | +78% | $0.000000 | 1,212,520 | 17 Nov 2021 | Common Stock | 530,488 | $28.58 | Direct | F8 |
| transaction | AXON | Employee Stock Option | Award | $0 | +530,488 | +44% | $0.000000 | 1,743,008 | 17 Nov 2021 | Common Stock | 530,488 | $28.58 | Direct | F8 |
| transaction | AXON | Employee Stock Option | Options Exercise | $0 | -11,982 | -0.69% | $0.000000 | 1,731,026 | 18 Nov 2021 | Common Stock | 11,982 | $28.58 | Direct | |
| transaction | AXON | Employee Stock Option | Options Exercise | $0 | -212,491 | -12% | $0.000000 | 1,518,535 | 19 Nov 2021 | Common Stock | 212,491 | $28.58 | Direct |
| Id | Content |
|---|---|
| F1 | This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. |
| F2 | Securities disposed represent securities sold to settle the reporting person's tax liability and exercise price pursuant to a filed Rule 10b5-1 plan. The remainder of the shares, with the exception of those reported on this Form 4, are subject to a 2.5 year holding period. |
| F3 | The transaction was executed in multiple trades at prices ranging from $180.00 to $180.50. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | The transaction was executed in multiple trades at prices ranging from $180.00 to $180.97. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | The transaction was executed in multiple trades at prices ranging from $181.00 to $181.99. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | The transaction was executed in multiple trades at prices ranging from $182.00 to $182.96. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | The transaction was executed in multiple trades at prices ranging from $183.00 to $183.40. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | The transaction consists of performance-based restricted stock options granted on February 26, 2018 (which was approved by shareholders and became effective on May 24, 2018) for the achievement of tranches nine and ten of the CEO Performance Award for which the performance conditions were determined to have been certified by the Compensation Committee on the transaction date. The options for these tranches vested on November 17, 2021. Once the options are exercised, the shares are subject to a 2.5 year minimum holding period, excluding shares withheld, sold or made available to sell to cover taxes. |